JNJ Johnson & Johnson
Healthcare · Close of 19 Nov 26
⭐ Log in to follow stocks and set price alerts (free) Log in
Financials (from SEC filings)
📅 Next earnings: 20 Jan 2027 · date estimated from last year
What changed in the latest quarter (Q3 2026)
Johnson & Johnson (JNJ) – Q3 2026 (ended Sep 27, 2026)
- Revenue: $25.4B, up 5.9% from the same quarter a year earlier
- Gross margin: 68.1%, slightly down from 69.6% a year ago
- Net income: only $210M, down 95.9% from a year ago (earlier quarters were around $5B)
- Net margin: 0.8% vs 21.5% a year ago
- EPS (earnings per share): $0.09, down 95.8%
- Operating margin: not available in this data
- Balance sheet: cash of $16.9B vs long-term debt of $35.8B
In simple terms: sales kept growing, but net profit fell sharply this quarter. The data does not say why. These are reported quarterly figures, not derived from the annual report.
| Quarter | Revenue | Net income | EPS | Net margin |
|---|---|---|---|---|
| Q3 2026ended 27 Sept 2026 | $25.4B+5.9% YoY | $210M-95.9% YoY | $0.09-95.8% YoY | 0.8% |
| Q2 2026ended 28 Jun 2026 | $25.3B+6.6% YoY | $5.5B-0.1% YoY | $2.27-0.9% YoY | 21.9% |
| Q1 2026ended 29 Mar 2026 | $24.1B+9.9% YoY | $5.2B-52.4% YoY | $2.14-52.9% YoY | 21.8% |
| Q4 2025*ended 28 Dec 2025 | $24.6B+9.1% YoY | $5.1B+49.1% YoY | $2.08+47.5% YoY | 20.8% |
| Q3 2025ended 28 Sept 2025 | $24.0B+6.8% YoY | $5.2B+91.2% YoY | $2.12+91.0% YoY | 21.5% |
| Q2 2025ended 29 Jun 2025 | $23.7B+5.8% YoY | $5.5B+18.2% YoY | $2.29+18.7% YoY | 23.3% |
YoY = vs the same quarter a year earlier · quarters follow the company's fiscal year * Q4 = full year minus the first three quarters (EPS approximate)
Balance sheet as of 2026-09-27: Cash $16.9B · Long-term debt $35.8B · Equity $81.5B
Numbers from SEC EDGAR (the company's 10-Q/10-K filings), updated daily · AI summary from the numbers only, not investment advice ·Open the 10-Q filed 2026-10-21
🏛 US Congress trades in this stock (12 months)
Reports can arrive up to 45 days after the trade and give amount ranges only. By the time you see this, the trade is old news: no inside information, not a trading signal.
| Filed | Member | Asset | Type | Amount (range) | Traded |
|---|---|---|---|---|---|
| 30 Oct 26PDF | Thomas H. Kean JrNJ07 · self | JNJJohnson & Johnson Common Stock | Partial sell | $1,001 - $15,000 | 30 Sept 2630 days later |
| 5 Oct 26PDF | Lloyd DoggettTX37 · self | JNJJohnson & Johnson Common Stock | Buy | $1,001 - $15,000 | 8 Sept 2627 days later |
| 12 Sept 26PDF | Thomas H. Kean JrNJ07 · self | JNJJohnson & Johnson Common Stock (JNJ) [ST] (Subholding of: State Street Bank & Trust Co.) | Partial sell | $1,001 - $15,000 | 27 Aug 2616 days later |
| 14 Aug 26PDF | Richard Dean Dr McCormickGA06 · self | JNJJohnson & Johnson Common Stock | Sell | $1,001 - $15,000 | 30 Jul 2615 days later |
Today's AI analysis
The AI is analysing this stock. Refresh in a moment.
⚖️ Compare JNJ with another stock
For education only, not a recommendation to buy or sell. Investing involves risk.